Rob Laverty

Rob brings over 28 years of pharmaceutical experience with more than 20 of those years being in the discipline of market access to his role at Braeburn as the Vice President of Market Access. Rob is responsible for payer engagement, pricing and contracting, trade and distribution and patient support services. Rob had previously served as the Vice President of Market Access at Otsuka America Pharmaceuticals prior to joining Braeburn. Rob held a variety of commercial roles with increasing responsibility while at Bristol Myers Squibb for 18 years. Rob began his professional career in accounting at IBM.